Cancer Biopsy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cancer

The Cancer Biopsy Market is estimated to be valued at US$22.86 Bn in 2022 and is expected to exhibit a CAGR of 14.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.